CHICAGO, IL—Following bioprosthetic valve surgery, anticoagulation with edoxaban (Savaysa; Daiichi Sankyo) is as effective as warfarin, although this strategy might come at a higher cost of bleeding, ...

"Our results suggest that edoxaban could be an alternative to warfarin for patients early after bioprosthetic valve surgery, which could offer more flexibility and convenience," she said during ...

Opens in a new tab or window CHICAGO -- Edoxaban (Savaysa) appeared at least on par with warfarin for 12-week thromboembolic prophylaxis after bioprosthetic valve surgical implant in a Japanese ...

“Currently, we can use only vitamin K antagonists such as warfarin for patients early after bioprosthetic valve surgery,” said lead study author Chisato Izumi, M.D., Ph.D., of the National ...

"Currently, we can use only vitamin K antagonists such as warfarin for patients early after bioprosthetic valve surgery," said lead study author Chisato Izumi, M.D., Ph.D., of the National ...

Currently, we can use only vitamin K antagonists such as warfarin for patients early after bioprosthetic valve surgery. However, warfarin has a narrow therapeutic range requiring frequent blood ...

All the cusps of the bioprosthesis appeared ... follow-up visit after 3 months the valve appeared normal. We told the patient that we recommended long-term anticoagulation with apixaban.

Medscape Medical News, December 02, 2024 AHA 2024 Anticoagulant Considered After Bioprosthetic Valve Surgery Edoxaban was at least as effective as warfarin in preventing thromboembolism after ...

Unlike warfarin, the standard treatment ... alternative to consider for patients who have received a bioprosthetic heart valve replacement," Izumi said in a meeting news release.